Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study

OBJECTIVE: PARADIGMS demonstrated superior efficacy and comparable safety of fingolimod versus interferon β-1a (IFN β-1a) in paediatric-onset multiple sclerosis (PoMS). This study aimed to report all predefined MRI outcomes from this study. METHODS: Patients with multiple sclerosis (MS) (aged 10–<...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Neurol Neurosurg Psychiatry
Main Authors: Arnold, Douglas L, Banwell, Brenda, Bar-Or, Amit, Ghezzi, Angelo, Greenberg, Benjamin M, Waubant, Emmanuelle, Giovannoni, Gavin, Wolinsky, Jerry S, Gärtner, Jutta, Rostásy, Kevin, Krupp, Lauren, Tardieu, Marc, Brück, Wolfgang, Stites, Tracy E, Pearce, Gregory L, Häring, Dieter A, Merschhemke, Martin, Chitnis, Tanuja
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2020
Fag:
Multiple Sclerosis
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7231437/
https://ncbi.nlm.nih.gov/pubmed/32132224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2019-322138
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker